Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2004-1-7
pubmed:abstractText
Recent studies on a limited number of pheochromocytomas (PCs) revealed a potential role of telomerase in the malignant transition of these tumors. Telomerase is a ribonucleoprotein complex that includes the telomerase RNA component (hTR), the telomerase-associated protein (TP1), the telomerase catalytic subunit (hTERT), and the heat-shock protein 90 (HSP90). The interactions between these subunits and the activation machinery of telomerase are still unclear. To test whether the expression and regulation of telomerase subunits are reflected in the malignant transition of PCs, we determined their mRNA and/or protein expression in 28 benign and 9 malignant PCs and compared the results with telomerase activity. Reverse transcriptase polymerase chain reaction analysis revealed that TP1 was ubiquitously expressed. hTR was found in all malignant (100%) and in 13/28 (46%) benign PCs. By contrast, hTERT was clearly associated with aggressive biologic behavior. All the malignant (100%) but only 2/28 benign (7%) PCs expressed hTERT. HSP90 was increased in malignant PCs but was also expressed at a lower level in benign tumors. High telomerase activity was measurable in only hTERT-positive tissues. Our data indicate that hTERT, HSP90, and telomerase activity are upregulated in malignant cells of the adrenal medulla. Overexpression of HSP90 is an important factor in the activation of telomerase via hTERT. The common expression of hTERT and telomerase activity thus represents an additional prognostic marker that may identify more aggressive tumors.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1355-008X
pubmed:author
pubmed:issnType
Print
pubmed:volume
22
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
193-201
pubmed:dateRevised
2010-6-24
pubmed:meshHeading
pubmed-meshheading:14709792-Adult, pubmed-meshheading:14709792-Aged, pubmed-meshheading:14709792-Carrier Proteins, pubmed-meshheading:14709792-Cell Transformation, Neoplastic, pubmed-meshheading:14709792-DNA-Binding Proteins, pubmed-meshheading:14709792-Enzyme Activation, pubmed-meshheading:14709792-Female, pubmed-meshheading:14709792-HSP90 Heat-Shock Proteins, pubmed-meshheading:14709792-Humans, pubmed-meshheading:14709792-Immunohistochemistry, pubmed-meshheading:14709792-Ki-67 Antigen, pubmed-meshheading:14709792-Male, pubmed-meshheading:14709792-Middle Aged, pubmed-meshheading:14709792-Multivariate Analysis, pubmed-meshheading:14709792-Pheochromocytoma, pubmed-meshheading:14709792-RNA, pubmed-meshheading:14709792-RNA, Neoplasm, pubmed-meshheading:14709792-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:14709792-Telomerase
pubmed:year
2003
pubmed:articleTitle
HSP90 is a key for telomerase activation and malignant transition in pheochromocytoma.
pubmed:affiliation
Department of Pathology, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany. carsten.boltze@medizin.uni-magdeburg.de
pubmed:publicationType
Journal Article, Retracted Publication